Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:A risk score to predict kidney survival in patients with autosomal recessive polycystic kidney disease at the age of two months
Authors:ID Burgmaier, Kathrin (Author)
ID Kilian, Samuel (Author)
ID Arbeiter, Klaus (Author)
ID Atmis, Bahriye (Author)
ID Boyer, Olivia (Author)
ID Buescher, Anja Katrin (Author)
ID Dursun, Ismail (Author)
ID Rus, Rina (Research coworker), et al.
Files:.pdf PDF - Presentation file, download (2,87 MB)
MD5: 29976BF9EEE67C569538DF254A25275E
 
URL URL - Source URL, visit https://www.kidney-international.org/article/S0085-2538(25)00086-9/fulltext
 
Language:English
Typology:1.02 - Review Article
Organization:Logo UKC LJ - Ljubljana University Medical Centre
Abstract:Autosomal recessive polycystic kidney disease (ARPKD) is a severe hepatorenal fibrocystic disorder. Its rareness and the variability of disease courses have been major obstacles for the establishment of clinical trials on treatment of kidney disease in ARPKD. In this observational study we characterized kidney disease progression in a very large cohort of up to 658 patients with the clinical diagnosis of ARPKD and identified risk factors associated with rapid kidney disease progression. The estimated probability of kidney failure by the age of 20 years was 50.1% (95% confidence interval 42.2%‒57.0%), with earlier kidney failure in specific subgroups. Mean yearly estimated glomerular filtration rate decline after the first year of life was 1.3 ml/min per 1.73 m2 during childhood and adolescence in the overall cohort, ranging from 0.5 to 2.2 ml/min per 1.73 m2 in various subgroups. Furthermore, we developed prediction models for the relative risk of early kidney failure to be applied at the age of two months in daily clinical life. The finally chosen predictor set for a score based on a Cox model encompassed five factors: gestational age at oligo- or anhydramnios, gestational age at birth, functional genotype, serum creatinine (mg/dl) as well as documentation of arterial hypertension at the age of two months. The derived simple prognostic score showed good prediction performance, especially in the first three years of life. It reliably identified patients who are not at risk of early kidney failure and may be helpful to identify patients at risk of more rapid disease progression that could benefit from novel therapeutic interventions.
Keywords:ciliopathies, fibrocystic hepatorenal disease, fibrocystin, kidney survival, polycystic kidney disease
Publication status:Published
Publication version:Version of Record
Year of publishing:2025
Number of pages:str. 903-915
Numbering:Vol. 107, issue 5
PID:20.500.12556/DiRROS-24122 New window
UDC:616.6
ISSN on article:1523-1755
DOI:10.1016/j.kint.2025.01.023 New window
COBISS.SI-ID:238027779 New window
Note:Nasl. z nasl. zaslona; Opis vira z dne 3. 6. 2025;
Publication date in DiRROS:14.11.2025
Views:172
Downloads:65
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Kidney international
Shortened title:Kidney int.
Publisher:Nature Publishing Group
ISSN:1523-1755
COBISS.SI-ID:2928148 New window

Document is financed by a project

Funder:EC - European Commission
Project number:101080717
Name:Therapies for Renal Ciliopathies
Acronym:TheRaCil

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Back